Valinor
Latest round
- Seed
Last raised
- Dec 2025
Total raised
- $13M
Investors
- 4
About Valinor
Valinor was founded in 2024 in San Francisco, US, focusing on advanced machine learning applications for the pharmaceutical and biotechnology sectors.Valinor specializes in advanced machine learning solutions designed to enhance clinical drug development by transforming traditional clinical trial methodologies. The company’s core product offerings include multi-modal virtual patient models that integrate comprehensive longitudinal data across various multi-omics and clinical assay samples. These models simulate therapeutic efficacy at the patient level, allowing for predictions of treatment outcomes prior to initiating clinical trials.Valinor's revenue model is primarily built around partnerships and B2B transactions within the pharmaceutical and biotech industries. The company engages clients through subscription-based access to their virtual patient simulation platforms, enabling pharmaceutical companies to leverage Valinor's advanced predictive capabilities in their clinical trials. The company plans to introduce new products designed to further optimize clinical trial methodologies. Additionally, Valinor seeks to expand its presence into new markets, particularly in Europe and Asia, by mid-2026, bolstering their global reach in pharmaceutical research.
Who invested in Valinor
4 investors across 1 round
See all investors in Valinor
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Dec 10, 2025
Amount
$13M
Investors
Questions about Valinor
Who invested in Valinor?
Valinor has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Valinor raised?
Valinor has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Valinor last raise money?
Valinor's most recent round on record is a Seed, in Dec 2025.
What does Valinor do?
Valinor was founded in 2024 in San Francisco, US, focusing on advanced machine learning applications for the pharmaceutical and biotechnology sectors.
Where is Valinor headquartered?
Valinor is headquartered in San Francisco, US.
Which VCs invest in companies like Valinor?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Valinor's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Valinor? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.